Cargando…
Celecoxib Is Associated With Dystrophic Calcification and Aortic Valve Stenosis
Calcific aortic valve disease is a progressive fibrocalcific process that can only be treated with valve replacement. Cadherin-11 has recently been identified as a potential therapeutic target for calcific aortic valve disease. The already approved drug celecoxib, a cyclooxygenase-2 inhibitor, binds...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488810/ https://www.ncbi.nlm.nih.gov/pubmed/31061914 http://dx.doi.org/10.1016/j.jacbts.2018.12.003 |